通过对疫苗上市后安全性进行独立监督来增强公众对疫苗的信心。
Enhancing public confidence in vaccines through independent oversight of postlicensure vaccine safety.
作者信息
Salmon Daniel A, Moulton Lawrence H, Halsey Neal A
机构信息
Institute for Vaccine Safety, Johns Hopkins University, Bloomberg School of Public Health, 615 N Wolfe Street, Suite 5034, Baltimore, MD 21205, USA.
出版信息
Am J Public Health. 2004 Jun;94(6):947-50. doi: 10.2105/ajph.94.6.947.
The National Immunization Program of the Centers for Disease Control and Prevention is responsible for controlling infectious diseases through vaccination, but the program also plays a key role in postlicensure vaccine safety assessment. The time has come to separate postlicensure vaccine safety assessment from vaccine risk management as recommended by the National Research Council of the National Academy of Sciences.The National Transportation Safety Board offers a useful model for developing an independent National Vaccine Safety Board that would have the authority to leverage resources and expertise of various government agencies, academia, and industry to oversee postlicensure vaccine safety investigations. Such a board would have been useful in recent vaccine safety concerns, and its independence from government programs would ensure optimal vaccine safety and enhance public confidence in vaccines.
疾病控制与预防中心的国家免疫规划负责通过接种疫苗来控制传染病，但该规划在疫苗上市后安全性评估中也发挥着关键作用。按照美国国家科学院国家研究理事会的建议，现在是时候将疫苗上市后安全性评估与疫苗风险管理区分开来了。国家运输安全委员会提供了一个有益的模式，可用于设立一个独立的国家疫苗安全委员会，该委员会将有权利用各政府机构、学术界和行业的资源与专业知识，监督疫苗上市后的安全性调查。这样一个委员会在近期的疫苗安全问题中会很有用，其独立于政府项目将确保最佳的疫苗安全性，并增强公众对疫苗的信心。
Zotero 插件